|
|
|
|
|
FORM 10-Q
|
[X]
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the quarterly period ended September 29, 2018
|
[ ]
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from ________ to ________.
|
Delaware
(State or Other Jurisdiction of Incorporation or Organization)
|
|
94-2896096
(I.R.S. Employer I. D. No.)
|
Large accelerated filer [x]
|
Accelerated filer [ ]
|
Non-accelerated filer [ ]
(Do not check if a smaller reporting company) |
Smaller reporting company [ ]
|
Emerging growth company [ ]
|
|
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisited financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
|
|
|
|
|
|
PART I - FINANCIAL INFORMATION
|
|
Page
|
|
|
|
Item 1. Financial Statements (Unaudited)
|
|
|
|
|
|
Condensed Consolidated Balance Sheets as of September 29, 2018 and June 30, 2018
|
|
|
|
|
|
Condensed Consolidated Statements of Income for the Three Months Ended September 29, 2018 and September 23, 2017
|
|
|
|
|
|
Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended September 29, 2018 and September 23, 2017
|
|
|
|
|
|
Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 29, 2018 and September 23, 2017
|
|
|
|
|
|
Notes to Condensed Consolidated Financial Statements
|
|
|
|
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
|
|
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
|
|
|
|
|
Item 4. Controls and Procedures
|
|
|
|
|
|
PART II - OTHER INFORMATION
|
|
|
|
|
|
Item 1. Legal Proceedings
|
|
|
|
|
|
Item 1A. Risk Factors
|
|
|
|
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
|
|
|
|
|
Item 3. Defaults Upon Senior Securities
|
|
|
|
|
|
Item 4. Mine Safety Disclosures
|
|
|
|
|
|
Item 5. Other Information
|
|
|
|
|
|
Item 6. Exhibits
|
|
|
|
|
|
SIGNATURES
|
|
|
September 29,
2018 |
|
June 30,
2018 |
||||
|
(in thousands)
|
||||||
ASSETS
|
|||||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
1,598,772
|
|
|
$
|
1,543,484
|
|
Short-term investments
|
964,643
|
|
|
1,082,915
|
|
||
Total cash, cash equivalents and short-term investments
|
2,563,415
|
|
|
2,626,399
|
|
||
Accounts receivable, net of allowances of $164 at September 29, 2018 and $140,296 at June 30, 2018
|
439,407
|
|
|
280,072
|
|
||
Inventories
|
275,374
|
|
|
282,390
|
|
||
Other current assets
|
33,329
|
|
|
21,548
|
|
||
Total current assets
|
3,311,525
|
|
|
3,210,409
|
|
||
Property, plant and equipment, net
|
573,014
|
|
|
579,364
|
|
||
Intangible assets, net
|
74,785
|
|
|
78,246
|
|
||
Goodwill
|
532,251
|
|
|
532,251
|
|
||
Other assets
|
56,977
|
|
|
51,291
|
|
||
TOTAL ASSETS
|
$
|
4,548,552
|
|
|
$
|
4,451,561
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|||||||
Current liabilities:
|
|
|
|
||||
Accounts payable
|
$
|
84,087
|
|
|
$
|
92,572
|
|
Price adjustment and other revenue reserves
|
135,187
|
|
|
—
|
|
||
Income taxes payable
|
60,877
|
|
|
17,961
|
|
||
Accrued salary and related expenses
|
106,273
|
|
|
151,682
|
|
||
Accrued expenses
|
42,091
|
|
|
35,774
|
|
||
Current portion of long-term debt
|
499,762
|
|
|
499,406
|
|
||
Total current liabilities
|
928,277
|
|
|
797,395
|
|
||
Long-term debt
|
991,506
|
|
|
991,147
|
|
||
Income taxes payable
|
652,163
|
|
|
661,336
|
|
||
Other liabilities
|
64,283
|
|
|
70,743
|
|
||
Total liabilities
|
2,636,229
|
|
|
2,520,621
|
|
||
|
|
|
|
||||
Commitments and contingencies (Note 11)
|
|
|
|
|
|
||
|
|
|
|
||||
Stockholders’ equity:
|
|
|
|
||||
Common stock and capital in excess of par value
|
279
|
|
|
279
|
|
||
Retained earnings
|
1,924,764
|
|
|
1,945,646
|
|
||
Accumulated other comprehensive loss
|
(12,720
|
)
|
|
(14,985
|
)
|
||
Total stockholders’ equity
|
1,912,323
|
|
|
1,930,940
|
|
||
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY
|
$
|
4,548,552
|
|
|
$
|
4,451,561
|
|
|
Three Months Ended
|
||||||
|
September 29,
2018 |
|
September 23,
2017 |
||||
|
(in thousands, except per share data)
|
||||||
|
|
|
|
||||
Net revenues
|
$
|
638,495
|
|
|
$
|
575,676
|
|
Cost of goods sold
|
208,259
|
|
|
201,845
|
|
||
Gross margin
|
430,236
|
|
|
373,831
|
|
||
Operating expenses:
|
|
|
|
||||
Research and development
|
112,708
|
|
|
108,601
|
|
||
Selling, general and administrative
|
81,518
|
|
|
73,681
|
|
||
Intangible asset amortization
|
773
|
|
|
1,752
|
|
||
Impairment of long-lived assets
|
—
|
|
|
42
|
|
||
Severance and restructuring expenses
|
994
|
|
|
5,433
|
|
||
Other operating expenses (income), net
|
60
|
|
|
(844
|
)
|
||
Total operating expenses
|
196,053
|
|
|
188,665
|
|
||
Operating income (loss)
|
234,183
|
|
|
185,166
|
|
||
Interest and other income (expense), net
|
(546
|
)
|
|
(4,214
|
)
|
||
Income (loss) before provision for income taxes
|
233,637
|
|
|
180,952
|
|
||
Income tax provision (benefit)
|
36,214
|
|
|
26,419
|
|
||
Net income (loss)
|
$
|
197,423
|
|
|
$
|
154,533
|
|
|
|
|
|
||||
Earnings (loss) per share:
|
|
|
|
||||
Basic
|
$
|
0.71
|
|
|
$
|
0.55
|
|
Diluted
|
$
|
0.70
|
|
|
$
|
0.54
|
|
|
|
|
|
||||
Shares used in the calculation of earnings (loss) per share:
|
|
|
|
||||
Basic
|
278,045
|
|
|
282,170
|
|
||
Diluted
|
282,454
|
|
|
286,437
|
|
||
|
|
|
|
||||
Dividends declared and paid per share
|
$
|
0.46
|
|
|
$
|
0.36
|
|
|
|
Three Months Ended
|
||||||
|
|
September 29,
2018 |
|
September 23,
2017 |
||||
|
|
(in thousands)
|
||||||
Net income (loss)
|
|
$
|
197,423
|
|
|
$
|
154,533
|
|
Other comprehensive income (loss), net of tax:
|
|
|
|
|
||||
Change in net unrealized gains and losses on available-for-sale securities, net of tax benefit (expense) of $(27) and $0, respectively
|
|
1,092
|
|
|
(98
|
)
|
||
Change in net unrealized gains and losses on cash flow hedges, net of tax benefit (expense) of $(214) and $(120), respectively
|
|
1,095
|
|
|
353
|
|
||
Change in net unrealized gains and losses on post-retirement benefits, net of tax benefit (expense) of $(19) and $(22), respectively
|
|
78
|
|
|
44
|
|
||
Other comprehensive income (loss), net
|
|
2,265
|
|
|
299
|
|
||
Total comprehensive income (loss)
|
|
$
|
199,688
|
|
|
$
|
154,832
|
|
|
Three Months Ended
|
||||||
|
September 29,
2018 |
|
September 23,
2017 |
||||
|
(in thousands)
|
||||||
Cash flows from operating activities:
|
|
|
|
||||
Net income (loss)
|
$
|
197,423
|
|
|
$
|
154,533
|
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
|
|
|
||||
Stock-based compensation
|
20,497
|
|
|
17,287
|
|
||
Depreciation and amortization
|
31,191
|
|
|
36,754
|
|
||
Deferred taxes
|
(3,032
|
)
|
|
12,115
|
|
||
Loss (gain) from sale of property, plant and equipment
|
621
|
|
|
61
|
|
||
Other adjustments
|
(117
|
)
|
|
42
|
|
||
Changes in assets and liabilities:
|
|
|
|
||||
Accounts receivable
|
(23,604
|
)
|
|
23,239
|
|
||
Inventories
|
7,002
|
|
|
1,835
|
|
||
Other current assets
|
(12,625
|
)
|
|
1,488
|
|
||
Accounts payable
|
(5,263
|
)
|
|
(9,979
|
)
|
||
Income taxes payable
|
33,743
|
|
|
16,333
|
|
||
Deferred margin on shipments to distributors
|
—
|
|
|
2,020
|
|
||
Accrued salary and related expenses
|
(45,408
|
)
|
|
(42,105
|
)
|
||
All other accrued liabilities
|
6,757
|
|
|
6,082
|
|
||
Net cash provided by (used in) operating activities
|
207,185
|
|
|
219,705
|
|
||
|
|
|
|
||||
Cash flows from investing activities:
|
|
|
|
||||
Purchases of property, plant and equipment
|
(18,316
|
)
|
|
(14,321
|
)
|
||
Proceeds from sale of property, plant and equipment
|
1
|
|
|
1,473
|
|
||
Proceeds from sale of available-for-sale securities
|
8,438
|
|
|
18,101
|
|
||
Proceeds from maturity of available-for-sale securities
|
301,834
|
|
|
—
|
|
||
Payment in connection with business acquisition, net of cash acquired
|
(2,949
|
)
|
|
—
|
|
||
Purchases of available-for-sale securities
|
(190,880
|
)
|
|
(716,304
|
)
|
||
Purchases of privately-held companies' securities
|
(750
|
)
|
|
(606
|
)
|
||
Net cash provided by (used in) investing activities
|
97,378
|
|
|
(711,657
|
)
|
||
|
|
|
|
||||
Cash flows from financing activities:
|
|
|
|
||||
Contingent consideration paid
|
(8,000
|
)
|
|
—
|
|
||
Net issuance of restricted stock units
|
(7,528
|
)
|
|
(5,416
|
)
|
||
Proceeds from stock options exercised
|
6,608
|
|
|
5,160
|
|
||
Repurchase of common stock
|
(112,498
|
)
|
|
(75,291
|
)
|
||
Dividends paid
|
(127,857
|
)
|
|
(101,462
|
)
|
||
Net cash provided by (used in) financing activities
|
(249,275
|
)
|
|
(177,009
|
)
|
||
|
|
|
|
||||
Net increase (decrease) in cash and cash equivalents
|
55,288
|
|
|
(668,961
|
)
|
||
Cash and cash equivalents:
|
|
|
|
||||
Beginning of period
|
$
|
1,543,484
|
|
|
$
|
2,246,121
|
|
End of period
|
$
|
1,598,772
|
|
|
$
|
1,577,160
|
|
|
|
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
||||
Cash paid, net, during the period for income taxes
|
$
|
10,988
|
|
|
$
|
502
|
|
Cash paid for interest
|
$
|
8,438
|
|
|
$
|
8,438
|
|
|
|
|
|
||||
Noncash financing and investing activities:
|
|
|
|
||||
Accounts payable related to property, plant and equipment purchases
|
$
|
5,590
|
|
|
$
|
3,375
|
|
|
As of June 30, 2018
|
|
Effect of Adoption of Topic 606
|
|
As of July 1, 2018
|
||||||
|
|
|
|
|
|
||||||
Accounts receivable, net
|
$
|
280,072
|
|
|
$
|
141,652
|
|
|
$
|
421,724
|
|
Price adjustment and other revenue reserves
|
—
|
|
|
141,652
|
|
|
141,652
|
|
|
As Reported
|
|
If Reported Under Topic 605
|
|
Effect of Adoption of Topic 606
|
||||||
|
|
|
|
|
|
||||||
Accounts receivable, net
|
$
|
439,407
|
|
|
$
|
304,220
|
|
|
$
|
135,187
|
|
Price adjustment and other revenue reserves
|
135,187
|
|
|
—
|
|
|
135,187
|
|
•
|
The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which we have the right to invoice for services performed.
|
•
|
The Company has elected to account for shipping and handling costs as fulfillment costs after the customer obtains control of the goods.
|
•
|
The Company has elected to exclude sales, use, value added, and some excise taxes, if applicable, from the measurement of the transaction price. The transaction price excludes sales and other similar taxes.
|
|
September 29,
2018 |
|
June 30,
2018 |
||||
Inventories:
|
(in thousands)
|
||||||
Raw materials
|
$
|
15,113
|
|
|
$
|
16,251
|
|
Work-in-process
|
170,192
|
|
|
173,859
|
|
||
Finished goods
|
90,069
|
|
|
92,280
|
|
||
|
$
|
275,374
|
|
|
$
|
282,390
|
|
|
September 29,
2018 |
|
June 30,
2018 |
||||
Property, plant and equipment, net:
|
(in thousands)
|
||||||
Land
|
$
|
17,731
|
|
|
$
|
17,731
|
|
Buildings and building improvements
|
258,403
|
|
|
254,733
|
|
||
Machinery, equipment and software
|
1,322,593
|
|
|
1,309,487
|
|
||
|
1,598,727
|
|
|
1,581,951
|
|
||
Less: accumulated depreciation
|
(1,025,713
|
)
|
|
(1,002,587
|
)
|
||
|
$
|
573,014
|
|
|
$
|
579,364
|
|
|
September 29,
2018 |
|
June 30,
2018 |
||||
Accrued salary and related expenses:
|
(in thousands)
|
||||||
Accrued vacation
|
$
|
30,483
|
|
|
$
|
30,695
|
|
Accrued bonus
|
29,844
|
|
|
92,288
|
|
||
Accrued salaries
|
15,476
|
|
|
8,210
|
|
||
ESPP Withholding
|
14,901
|
|
|
5,158
|
|
||
Accrued fringe benefits
|
4,625
|
|
|
4,752
|
|
||
Other
|
10,944
|
|
|
10,579
|
|
||
|
$
|
106,273
|
|
|
$
|
151,682
|
|
|
As of September 29, 2018
|
|
As of June 30, 2018
|
||||||||||||||||||||||||||||
|
Fair Value
Measurements Using
|
|
Total
Balance
|
|
Fair Value
Measurements Using
|
|
Total
Balance |
||||||||||||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
||||||||||||||||||
|
(in thousands)
|
||||||||||||||||||||||||||||||
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Cash and cash equivalents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Agency securities
|
$
|
—
|
|
|
$
|
2,669
|
|
|
$
|
—
|
|
|
$
|
2,669
|
|
|
$
|
—
|
|
|
$
|
13,946
|
|
|
$
|
—
|
|
|
$
|
13,946
|
|
Certificates of deposit
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
6,000
|
|
|
—
|
|
|
6,000
|
|
||||||||
Commercial paper
|
—
|
|
|
52,145
|
|
|
—
|
|
|
52,145
|
|
|
—
|
|
|
45,063
|
|
|
—
|
|
|
45,063
|
|
||||||||
Corporate debt securities
|
—
|
|
|
12,237
|
|
|
—
|
|
|
12,237
|
|
|
—
|
|
|
3,819
|
|
|
—
|
|
|
3,819
|
|
||||||||
Money market funds
|
104,961
|
|
|
—
|
|
|
—
|
|
|
104,961
|
|
|
98,467
|
|
|
—
|
|
|
—
|
|
|
98,467
|
|
||||||||
U.S. Treasury securities
|
—
|
|
|
49,881
|
|
|
—
|
|
|
49,881
|
|
|
—
|
|
|
30,988
|
|
|
—
|
|
|
30,988
|
|
||||||||
Short term investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Certificates of deposit
|
—
|
|
|
63,940
|
|
|
—
|
|
|
63,940
|
|
|
—
|
|
|
52,428
|
|
|
—
|
|
|
52,428
|
|
||||||||
Commercial paper
|
—
|
|
|
71,666
|
|
|
—
|
|
|
71,666
|
|
|
—
|
|
|
64,354
|
|
|
—
|
|
|
64,354
|
|
||||||||
Corporate debt securities
|
—
|
|
|
345,669
|
|
|
—
|
|
|
345,669
|
|
|
—
|
|
|
367,765
|
|
|
—
|
|
|
367,765
|
|
||||||||
U.S. Treasury securities
|
—
|
|
|
483,368
|
|
|
—
|
|
|
483,368
|
|
|
—
|
|
|
598,368
|
|
|
—
|
|
|
598,368
|
|
||||||||
Other current assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Foreign currency forward contracts
|
—
|
|
|
293
|
|
|
—
|
|
|
293
|
|
|
—
|
|
|
235
|
|
|
—
|
|
|
235
|
|
||||||||
Total assets
|
$
|
104,961
|
|
|
$
|
1,081,868
|
|
|
$
|
—
|
|
|
$
|
1,186,829
|
|
|
$
|
98,467
|
|
|
$
|
1,182,966
|
|
|
$
|
—
|
|
|
$
|
1,281,433
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Accrued expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Foreign currency forward contracts
|
$
|
—
|
|
|
$
|
561
|
|
|
$
|
—
|
|
|
$
|
561
|
|
|
$
|
—
|
|
|
$
|
1,845
|
|
|
$
|
—
|
|
|
$
|
1,845
|
|
Contingent consideration
|
—
|
|
|
—
|
|
|
9,052
|
|
|
9,052
|
|
|
—
|
|
|
—
|
|
|
8,000
|
|
|
8,000
|
|
||||||||
Other liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Contingent consideration
|
—
|
|
|
—
|
|
|
1,052
|
|
|
1,052
|
|
|
—
|
|
|
—
|
|
|
8,000
|
|
|
8,000
|
|
||||||||
Total Liabilities
|
$
|
—
|
|
|
$
|
561
|
|
|
$
|
10,104
|
|
|
$
|
10,665
|
|
|
$
|
—
|
|
|
$
|
1,845
|
|
|
$
|
16,000
|
|
|
$
|
17,845
|
|
|
September 29,
2018 |
|
June 30,
2018 |
||||||||||||||||||||||||||||
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Estimated Fair Value
|
|
Amortized Cost
|
|
Gross Unrealized Gain
|
|
Gross Unrealized Loss
|
|
Estimated Fair Value
|
||||||||||||||||
|
(in thousands)
|
||||||||||||||||||||||||||||||
Available-for-sale investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Certificates of deposit
|
$
|
63,940
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
63,940
|
|
|
$
|
52,429
|
|
|
$
|
—
|
|
|
$
|
(1
|
)
|
|
$
|
52,428
|
|
Commercial paper
|
71,666
|
|
|
—
|
|
|
—
|
|
|
71,666
|
|
|
64,354
|
|
|
—
|
|
|
—
|
|
|
64,354
|
|
||||||||
Corporate debt securities
|
347,147
|
|
|
52
|
|
|
(1,530
|
)
|
|
345,669
|
|
|
369,734
|
|
|
39
|
|
|
(2,008
|
)
|
|
367,765
|
|
||||||||
U.S. Treasury securities
|
484,468
|
|
|
—
|
|
|
(1,100
|
)
|
|
483,368
|
|
|
600,068
|
|
|
10
|
|
|
(1,710
|
)
|
|
598,368
|
|
||||||||
Total available-for-sale investments
|
$
|
967,221
|
|
|
$
|
52
|
|
|
$
|
(2,630
|
)
|
|
$
|
964,643
|
|
|
$
|
1,086,585
|
|
|
$
|
49
|
|
|
$
|
(3,719
|
)
|
|
$
|
1,082,915
|
|
|
September 29,
2018 |
September 23,
2017 |
||||||||||||||||||||
|
Net Revenue
|
|
Cost of Goods Sold
|
|
Operating Expenses
|
Net Revenue
|
|
Cost of Goods Sold
|
|
Operating Expenses
|
||||||||||||
|
(in thousands)
|
|||||||||||||||||||||
Income and expenses line items in which the effects of cash flow hedges are recorded
|
$
|
638,495
|
|
|
$
|
208,259
|
|
|
$
|
196,053
|
|
$
|
575,676
|
|
|
$
|
201,845
|
|
|
$
|
188,665
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Gain (loss) on cash flow hedges:
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Foreign exchange contracts:
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Gain (loss) reclassified from accumulated other comprehensive income into income
|
$
|
39
|
|
|
$
|
(514
|
)
|
|
$
|
(1,225
|
)
|
$
|
(41
|
)
|
|
$
|
3
|
|
|
$
|
1,148
|
|
|
September 29,
2018 |
|
June 30,
2018 |
||||
|
(in thousands)
|
||||||
3.45% fixed rate notes due June 2027
|
$
|
500,000
|
|
|
$
|
500,000
|
|
2.5% fixed rate notes due November 2018
|
500,000
|
|
|
500,000
|
|
||
3.375% fixed rate notes due March 2023
|
500,000
|
|
|
500,000
|
|
||
Total outstanding debt
|
1,500,000
|
|
|
1,500,000
|
|
||
Less: Current portion (included in "Current portion of debt")
|
(499,762
|
)
|
|
(499,406
|
)
|
||
Less: Reduction for unamortized discount and debt issuance costs
|
(8,732
|
)
|
|
(9,447
|
)
|
||
Total long-term debt
|
$
|
991,506
|
|
|
$
|
991,147
|
|
|
Three Months Ended
|
||||||||||||||||||||||||||||||
|
September 29, 2018
|
|
September 23, 2017
|
||||||||||||||||||||||||||||
|
Stock Options
|
|
Restricted Stock Units
|
|
Employee Stock Purchase Plan
|
|
Total
|
|
Stock Options
|
|
Restricted Stock Units
|
|
Employee Stock Purchase Plan
|
|
Total
|
||||||||||||||||
|
(in thousands)
|
||||||||||||||||||||||||||||||
Cost of goods sold
|
$
|
10
|
|
|
$
|
1,761
|
|
|
$
|
507
|
|
|
$
|
2,278
|
|
|
$
|
86
|
|
|
$
|
1,836
|
|
|
$
|
478
|
|
|
$
|
2,400
|
|
Research and development
|
11
|
|
|
8,692
|
|
|
1,155
|
|
|
9,858
|
|
|
308
|
|
|
6,588
|
|
|
970
|
|
|
7,866
|
|
||||||||
Selling, general and administrative
|
56
|
|
|
7,645
|
|
|
661
|
|
|
8,362
|
|
|
363
|
|
|
6,130
|
|
|
528
|
|
|
7,021
|
|
||||||||
Pre-tax stock-based compensation expense
|
$
|
77
|
|
|
$
|
18,098
|
|
|
$
|
2,323
|
|
|
$
|
20,498
|
|
|
$
|
757
|
|
|
$
|
14,554
|
|
|
$
|
1,976
|
|
|
$
|
17,287
|
|
Less: income tax effect
|
|
|
|
|
|
|
1,964
|
|
|
|
|
|
|
|
|
2,890
|
|
||||||||||||||
Net stock-based compensation expense
|
|
|
|
|
|
|
|
|
$
|
18,534
|
|
|
|
|
|
|
|
|
$
|
14,397
|
|
|
Number of
Shares
|
|
Weighted Average Exercise Price
|
|
Weighted Average Remaining Contractual Term (in Years)
|
|
Aggregate Intrinsic Value (1)
|
|||||
Balance at June 30, 2018
|
1,688,253
|
|
|
$
|
27.72
|
|
|
|
|
|
||
Options Granted
|
—
|
|
|
—
|
|
|
|
|
|
|||
Options Exercised
|
(331,332
|
)
|
|
26.66
|
|
|
|
|
|
|||
Options Cancelled
|
(3,439
|
)
|
|
28.08
|
|
|
|
|
|
|||
Balance at September 29, 2018
|
1,353,482
|
|
|
$
|
27.98
|
|
|
1.7
|
|
$
|
42,687,390
|
|
Exercisable, September 29, 2018
|
1,353,482
|
|
|
$
|
27.98
|
|
|
1.7
|
|
$
|
42,687,390
|
|
Vested and expected to vest, September 29, 2018
|
1,353,482
|
|
|
$
|
27.98
|
|
|
1.7
|
|
$
|
42,687,390
|
|
(1)
|
Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on September 28, 2018, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of September 29, 2018.
|
|
Number of
Shares
|
|
Weighted Average
Remaining Contractual Term (in Years) |
|
Aggregate Intrinsic
Value (1)
|
|||
Balance at June 30, 2018
|
5,524,432
|
|
|
|
|
|
||
Restricted stock units and other awards granted
|
1,232,654
|
|
|
|
|
|
||
Restricted stock units and other awards released
|
(407,431
|
)
|
|
|
|
|
||
Restricted stock units and other awards cancelled
|
(127,997
|
)
|
|
|
|
|
||
Balance at September 29, 2018
|
6,221,658
|
|
|
3.0
|
|
$
|
370,516,643
|
|
Outstanding and expected to vest, September 29, 2018
|
5,121,814
|
|
|
2.9
|
|
$
|
304,850,402
|
|
(1)
|
Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on September 28, 2018, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of September 29, 2018.
|
|
Number of
Shares
|
|
Weighted Average
Remaining Contractual Term (in Years) |
|
Aggregate Intrinsic
Value (1)
|
|||
Balance at June 30, 2018
|
1,079,064
|
|
|
|
|
|
||
Market stock units granted
|
247,804
|
|
|
|
|
|
||
Market stock units released
|
(13,594
|
)
|
|
|
|
|
||
Market stock units cancelled
|
(245,082
|
)
|
|
|
|
|
||
Balance at September 29, 2018
|
1,068,192
|
|
|
3.1
|
|
$
|
63,578,788
|
|
Outstanding and expected to vest, September 29, 2018
|
925,295
|
|
|
3.0
|
|
$
|
55,073,544
|
|
(1)
|
Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on September 28, 2018, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of September 29, 2018.
|
|
Three Months Ended
|
||
|
September 29,
2018 |
|
September 23,
2017 |
Expected holding period (in years)
|
0.5 years
|
|
0.5 years
|
Risk-free interest rate
|
1.6% - 2.1%
|
|
0.8% - 1.1%
|
Expected stock price volatility
|
19.6% - 32.7%
|
|
19.1% - 24.7%
|
Dividend yield
|
2.8% -3.1%
|
|
3.0% - 3.4%
|
|
Three Months Ended
|
||||||
|
September 29,
2018 |
|
September 23,
2017 |
||||
|
(in thousands, except per share data)
|
||||||
Numerator for basic earnings (loss) per share and diluted earnings (loss) per share
|
|
|
|
||||
Net income (loss)
|
$
|
197,423
|
|
|
$
|
154,533
|
|
|
|
|
|
||||
Denominator for basic earnings (loss) per share
|
278,045
|
|
|
282,170
|
|
||
Effect of dilutive securities:
|
|
|
|
||||
Stock options, ESPP, RSUs, and MSUs
|
4,409
|
|
|
4,267
|
|
||
Denominator for diluted earnings (loss) per share
|
282,454
|
|
|
286,437
|
|
||
|
|
|
|
||||
Earnings (loss) per share
|
|
|
|
||||
Basic
|
$
|
0.71
|
|
|
$
|
0.55
|
|
Diluted
|
$
|
0.70
|
|
|
$
|
0.54
|
|
|
September 29,
2018 |
|
June 30,
2018 |
||||
|
(in thousands)
|
||||||
United States
|
$
|
360,958
|
|
|
$
|
361,432
|
|
Philippines
|
116,282
|
|
|
120,657
|
|
||
Rest of World
|
95,774
|
|
|
97,275
|
|
||
|
$
|
573,014
|
|
|
$
|
579,364
|
|
(in thousands)
|
Unrealized Gains and Losses on Intercompany Receivables
|
|
Unrealized Gains and Losses on Post-Retirement Benefits
|
|
Cumulative Translation Adjustment
|
|
Unrealized Gains and Losses on Cash Flow Hedges
|
|
Unrealized Gains and Losses on Available-For-Sale Securities
|
|
Total
|
||||||||||||
June 30, 2018
|
$
|
(6,280
|
)
|
|
$
|
(2,516
|
)
|
|
$
|
(1,136
|
)
|
|
$
|
(1,383
|
)
|
|
$
|
(3,670
|
)
|
|
$
|
(14,985
|
)
|
Other comprehensive income (loss) before reclassifications
|
—
|
|
|
—
|
|
|
—
|
|
|
(391
|
)
|
|
1,119
|
|
|
728
|
|
||||||
Amounts reclassified out of accumulated other comprehensive loss (income)
|
—
|
|
|
97
|
|
|
—
|
|
|
1,700
|
|
|
—
|
|
|
1,797
|
|
||||||
Tax effects
|
—
|
|
|
(19
|
)
|
|
—
|
|
|
(214
|
)
|
|
(27
|
)
|
|
(260
|
)
|
||||||
Other comprehensive income (loss), net
|
—
|
|
|
78
|
|
|
—
|
|
|
1,095
|
|
|
1,092
|
|
|
2,265
|
|
||||||
September 29, 2018
|
$
|
(6,280
|
)
|
|
$
|
(2,438
|
)
|
|
$
|
(1,136
|
)
|
|
$
|
(288
|
)
|
|
$
|
(2,578
|
)
|
|
$
|
(12,720
|
)
|
(in thousands)
|
Unrealized Gains and Losses on Intercompany Receivables
|
|
Unrealized Gains and Losses on Post-Retirement Benefits
|
|
Cumulative Translation Adjustment
|
|
Unrealized Gains and Losses on Cash Flow Hedges
|
|
Unrealized Gains and Losses on Available-For-Sale Securities
|
|
Total
|
||||||||||||
June 24, 2017
|
$
|
(6,280
|
)
|
|
$
|
(1,258
|
)
|
|
$
|
(1,136
|
)
|
|
$
|
18
|
|
|
$
|
(1,234
|
)
|
|
$
|
(9,890
|
)
|
Other comprehensive income (loss) before reclassifications
|
—
|
|
|
—
|
|
|
—
|
|
|
1,583
|
|
|
(98
|
)
|
|
1,485
|
|
||||||
Amounts reclassified out of accumulated other comprehensive loss (income)
|
—
|
|
|
66
|
|
|
—
|
|
|
(1,110
|
)
|
|
—
|
|
|
(1,044
|
)
|
||||||
Tax effects
|
—
|
|
|
(22
|
)
|
|
—
|
|
|
(120
|
)
|
|
—
|
|
|
(142
|
)
|
||||||
Other comprehensive income (loss), net
|
—
|
|
|
44
|
|
|
—
|
|
|
353
|
|
|
(98
|
)
|
|
299
|
|
||||||
September 23, 2017
|
$
|
(6,280
|
)
|
|
$
|
(1,214
|
)
|
|
$
|
(1,136
|
)
|
|
$
|
371
|
|
|
$
|
(1,332
|
)
|
|
$
|
(9,591
|
)
|
|
September 29,
2018 |
|
June 30,
2018 |
||||||||||||||||||||
|
Original
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
Original
Cost
|
|
Accumulated
Amortization
|
|
Net
|
||||||||||||
|
(in thousands)
|
||||||||||||||||||||||
Intellectual property
|
$
|
488,846
|
|
|
$
|
430,784
|
|
|
$
|
58,062
|
|
|
$
|
485,465
|
|
|
$
|
423,869
|
|
|
$
|
61,596
|
|
Customer relationships
|
116,505
|
|
|
103,885
|
|
|
12,620
|
|
|
116,294
|
|
|
103,217
|
|
|
13,077
|
|
||||||
Trade name
|
9,974
|
|
|
8,661
|
|
|
1,313
|
|
|
9,340
|
|
|
8,588
|
|
|
752
|
|
||||||
Patents
|
2,500
|
|
|
2,500
|
|
|
—
|
|
|
2,500
|
|
|
2,469
|
|
|
31
|
|
||||||
Total amortizable purchased intangible assets
|
617,825
|
|
|
545,830
|
|
|
71,995
|
|
|
613,599
|
|
|
538,143
|
|
|
75,456
|
|
||||||
IPR&D
|
2,790
|
|
|
—
|
|
|
2,790
|
|
|
2,790
|
|
|
—
|
|
|
2,790
|
|
||||||
Total purchased intangible assets
|
$
|
620,615
|
|
|
$
|
545,830
|
|
|
$
|
74,785
|
|
|
$
|
616,389
|
|
|
$
|
538,143
|
|
|
$
|
78,246
|
|
|
Three Months Ended
|
||||||
|
September 29,
2018 |
|
September 23,
2017 |
||||
|
(in thousands)
|
||||||
Cost of goods sold
|
$
|
6,915
|
|
|
$
|
11,064
|
|
Intangible asset amortization
|
773
|
|
|
1,752
|
|
||
Total intangible asset amortization expenses
|
$
|
7,688
|
|
|
$
|
12,816
|
|
Fiscal Year
|
|
Amount
|
||
|
|
(in thousands)
|
||
Remaining nine months of 2019
|
|
$
|
17,267
|
|
2020
|
|
15,368
|
|
|
2021
|
|
13,669
|
|
|
2022
|
|
7,989
|
|
|
2023
|
|
7,505
|
|
|
Thereafter
|
|
10,197
|
|
|
Total intangible assets
|
|
$
|
71,995
|
|
|
Balance, June 30, 2018
|
|
Three Months Ended
September 29, 2018
|
|
Balance, September 29, 2018
|
||||||||||
|
Charges
|
|
Cash Payments
|
|
Change in Estimates
|
|
|||||||||
|
|
|
|
|
(in thousands)
|
|
|
|
|
||||||
Severance and Related - All plans (1)
|
2,969
|
|
|
987
|
|
|
(3,139
|
)
|
|
7
|
|
|
$
|
824
|
|
(1)
|
Charges and change in estimates are included in Severance and restructuring expenses in the accompanying Condensed Consolidated Statements of Income.
|
|
Three Months Ended
|
||||
|
September 29,
2018 |
|
September 23,
2017 |
||
|
|
|
|
||
Net revenues
|
100.0
|
%
|
|
100.0
|
%
|
Cost of goods sold
|
32.6
|
%
|
|
35.1
|
%
|
Gross margin
|
67.4
|
%
|
|
64.9
|
%
|
Operating expenses:
|
|
|
|
||
Research and development
|
17.7
|
%
|
|
18.9
|
%
|
Selling, general and administrative
|
12.8
|
%
|
|
12.8
|
%
|
Intangible asset amortization
|
0.1
|
%
|
|
0.3
|
%
|
Impairment of long-lived assets
|
—
|
%
|
|
—
|
%
|
Severance and restructuring expenses
|
0.2
|
%
|
|
0.9
|
%
|
Other operating expenses (income), net
|
—
|
%
|
|
(0.1
|
)%
|
Total operating expenses
|
30.7
|
%
|
|
32.8
|
%
|
Operating income (loss)
|
36.7
|
%
|
|
32.2
|
%
|
Interest and other income (expense), net
|
(0.1
|
)%
|
|
(0.7
|
)%
|
Income before provision for income taxes
|
36.6
|
%
|
|
31.4
|
%
|
Income tax provision (benefit)
|
5.7
|
%
|
|
4.6
|
%
|
Net income (loss)
|
30.9
|
%
|
|
26.8
|
%
|
|
Three Months Ended
|
||||
|
September 29,
2018 |
|
September 23,
2017 |
||
Cost of goods sold
|
0.5
|
%
|
|
0.4
|
%
|
Research and development
|
1.4
|
%
|
|
1.4
|
%
|
Selling, general and administrative
|
1.2
|
%
|
|
1.2
|
%
|
|
3.1
|
%
|
|
3.0
|
%
|
|
Three Months Ended
|
||||||
|
September 29,
2018 |
|
September 23,
2017 |
||||
|
(in thousands)
|
||||||
Net cash provided by (used in) operating activities
|
$
|
207,185
|
|
|
$
|
219,705
|
|
Net cash provided by (used in) investing activities
|
97,378
|
|
|
(711,657
|
)
|
||
Net cash provided by (used in) financing activities
|
(249,275
|
)
|
|
(177,009
|
)
|
||
Net increase (decrease) in cash and cash equivalents
|
$
|
55,288
|
|
|
$
|
(668,961
|
)
|
|
Issuer Repurchases of Equity Securities
|
||||||||||||
|
(in thousands, except per share amounts)
|
||||||||||||
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
|
||||||
Jul 1, 2018 - Jul 28, 2018
|
554
|
|
|
$
|
60.16
|
|
|
554
|
|
|
$
|
585,052
|
|
Jul 29, 2018 - Aug 25, 2018
|
585
|
|
|
61.45
|
|
|
585
|
|
|
549,071
|
|
||
Aug 26, 2018 - Sep 29, 2018
|
723
|
|
|
59.75
|
|
|
723
|
|
|
505,861
|
|
||
Total for the quarter
|
1,862
|
|
|
$
|
60.41
|
|
|
1,862
|
|
|
$
|
505,861
|
|
(A) Management contract or compensatory plan or arrangement.
|
||||
(1) This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.
|
November 1, 2018
|
|
MAXIM INTEGRATED PRODUCTS, INC.
|
|
|
|
|
|
By:/s/
Sumeet Gagneja
|
|
|
|
|
|
Sumeet Gagneja
|
|
|
Vice President, Chief Accounting Officer
|
|
|
(Chief Accounting Officer and Duly Authorized Officer)
|
(A) =
|
The product of (1) the Target Shares, multiplied by (2) Performance Attainment Multiplier for the Performance Period;
|
(B) =
|
Sum of the Annual Banked Shares for each of the three Interim Periods.
|
1.
|
I hereby elect to participate in the Maxim Integrated Products, Inc. 2008 Employee Stock Purchase Plan (the “Plan”) and subscribe to purchase shares of the Company’s Common Stock, in accordance with this Enrollment Form Agreement, any special terms and conditions for my country
1
set forth in Appendix I (attached to this Enrollment Form Agreement) and the Plan. Unless otherwise defined herein, capitalized terms shall have the meaning ascribed to such terms in the Plan.
|
2.
|
I hereby authorize payroll deductions from each paycheck in the amount I specified in the online enrollment process through Morgan Stanley’s website (from 1 to 25%, in increments of 1%) of my Eligible Compensation on each payday during the Offer Period in accordance with the Plan.
|
3.
|
I understand that I will be deemed to have elected to participate and authorized the same percentage of payroll deductions, and my participation in the Plan will automatically remain in effect, from one Offer Period to the next in accordance with my payroll deduction authorization, unless I withdraw from the Plan or my employment status changes. To increase or reduce the rate of my payroll deductions, I understand I will have to complete a new enrollment through Morgan Stanley’s website during the Enrollment Period for the subsequent Offer Period, and the change in my rate of payroll deductions will become effective only at the beginning of the subsequent Offer Period.
|
4.
|
I understand that my payroll deductions shall be accumulated in a Payroll Account in my name for the purchase of Shares on the Purchase Date at the applicable purchase price as determined in Section 5 below (the “Purchase Price”). I understand that unless I withdraw from an Offer Period or my employment status changes, any accumulated payroll deductions will be used to automatically exercise my right to purchase the number of whole Shares which the balance of my Payroll Account will purchase on the Purchase Date by dividing the balance of my Payroll Account by the Purchase Price.
|
5.
|
I understand that the Purchase Price for each Share shall be the lesser of (i) 85% of the Fair Market Value of such Shares on the Offer Date and (ii) 85% of the Fair Market Value of such Shares on the Purchase Date.
|
6.
|
I acknowledge that the Plan and a prospectus relating to the Plan have been made available to me. I understand that my participation in the Plan is in all respects subject to the terms of the Plan.
|
7.
|
I acknowledge that, regardless of any action taken by the Company and/or, if different, my employer (the “Employer”), the ultimate liability for any and all income tax (including U.S., federal, state and local tax and/or non-U.S. tax), social insurance, fringe benefit tax, payroll tax, payment on account or other tax-related items related to my participation in the Plan and legally applicable to me or deemed by the Company or the Employer in their reasonable discretion to be an appropriate charge to me even if legally applicable to the Company or Employer (“Tax-Related Items”) is and remains my responsibility and may exceed the amount, if any, actually withheld by the Company or the Employer. I further acknowledge that the Company and/or the Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of
|
(a)
|
withholding from my wages or other cash compensation paid to me by the Company and/or the Employer;
|
(b)
|
withholding from proceeds of the sale of Shares acquired upon exercise of the right to purchase Shares either through a voluntary sale or through a mandatory sale arranged by the Company (on my behalf pursuant to this authorization); or
|
(c)
|
withholding in Shares to be issued upon exercise of the right to purchase Shares, provided, however, that if I am a Section 16 officer of the Company under the Exchange Act and I am participating in the Non-423(b) Component, then the obligation for Tax-Related Items will be satisfied by one or a combination of methods (a) and (b) above.
|
8.
|
I understand that if I am a U.S. taxpayer (regardless of whether I am also subject to tax in any other country) participating in the Code Section 423(b) component of the Plan
I should check with the Company to determine whether this requirement applies to me.
and I dispose of any Shares acquired under the Plan before the later to occur of: (1) two years after the first day of the Offer Period during which I purchased such Shares, and (2) one year after the Purchase Date, then I will be treated for U.S. federal income tax purposes as having received ordinary income at the time of such disposition in an amount equal to the excess of the Fair Market Value of the Shares at the time such Shares were purchased over the Purchase Price paid for the Shares, regardless of whether I sold such Shares for a gain or a loss. In such circumstances, I hereby agree to notify the Company in writing prior to the end of the calendar year in which any Shares were disposed of and to make adequate provisions for Tax-Related Items which arise upon the disposition of the Shares.
|
9.
|
By completing the online enrollment process and participating in the Plan, I understand, acknowledge and agree that:
|
10.
|
The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding my participation in the Plan, or my acquisition or sale of the underlying Shares. I should consult with my own personal tax, legal and financial advisors regarding my participation in the Plan before taking any action related to the Plan.
|
11.
|
I hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of my personal data as described in this Enrollment Form Agreement and any other Plan materials by and among, as applicable, the Employer, the Company and any other Subsidiary or Affiliate for the exclusive purpose of implementing, administering and managing my participation in the Plan.
|
12.
|
Except as may be approved by the Committee, the right to purchase Shares under the Plan is not transferable, except by will or by the laws of descent and distribution, and is exercisable during my lifetime only by me.
|
13.
|
If I have received this Enrollment Form Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different from the English version, the English version will control.
|
14.
|
I acknowledge that the Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. I hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an online or electronic system established and maintained by the Company or a third party designated by the Company.
|
15.
|
This grant of rights to purchase Shares and the provisions of this Enrollment Form Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to its conflict of law rules, as provided in the Plan. For purposes of litigating any dispute that arises directly or indirectly from the relationship of the parties evidenced by this grant of the right to purchase Shares or this Enrollment Form Agreement, the parties hereby submit to and consent to the exclusive jurisdiction of the State of California and agree that such litigation shall be conducted only in the courts of Santa Clara County, California, or the federal courts for the United States for the Northern District of California, and no other courts, where this grant is made and/or to be performed.
|
16.
|
The provisions of this Enrollment Form Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.
|
17.
|
Notwithstanding any provisions in this Enrollment Form Agreement, the grant of rights to purchase Shares and my participation in the Plan shall be subject to any special terms and conditions for my country set forth in Appendix I (attached to this Enrollment Form Agreement). Moreover, if I transfer residence and/or employment to, or am considered a citizen or resident for local law purposes of, one of the countries included in Appendix I, the special terms and conditions for such country will apply to me, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. Appendix I constitutes part of this Enrollment Form Agreement.
|
18.
|
The Company reserves the right to impose other requirements on my participation in the Plan, on the right to purchase Shares and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require me to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
|
19.
|
I acknowledge that I may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, including the United States and my country, if different, which may affect my ability, directly or indirectly, to acquire or sell, or attempt to sell, Shares or rights to Shares (e.g., rights to purchase Shares) under the Plan during such times as I am considered to have “inside information” regarding the Company (as defined by the laws in the applicable jurisdiction) or the trade in Shares or the trade in rights to Shares under the Plan. Any restrictions under these laws or regulations may be separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. I acknowledge that it is my responsibility to comply with any applicable restrictions, and that I should speak to my personal advisor on this matter.
|
20.
|
I acknowledge that my country may have certain foreign asset and/or account reporting requirements and/or exchange controls which may affect my ability to acquire or hold Shares under the Plan or cash received from participating in the Plan (including from any dividends received or sale proceeds arising from the sale of Shares) in a brokerage or bank account outside my country. I may be required to report such accounts, assets or transactions to the tax or other authorities in my country. I also may be required to repatriate sale proceeds or other funds received as a result of my participation in the Plan to my country through a designated bank or broker and/or within a certain time after receipt. I further acknowledge that it is my responsibility to be compliant with such regulations, and that I should consult my personal legal advisor for any details.
|
21.
|
I acknowledge that a waiver by the Company of breach of any provision of this Enrollment Form Agreement shall not operate or be construed as a waiver of any provision of this Enrollment Form Agreement, or of any subsequent breach by me or any other participant.
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Maxim Integrated Products, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
|
Date:
|
November 1, 2018
|
/s/ Tunç Doluca
|
|
|
|
|
|
|
|
|
|
Tunç Doluca
|
|
|
|
|
President and Chief Executive Officer
|
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Maxim Integrated Products, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15 (e) and 15d-15 (e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
|
Date:
|
November 1, 2018
|
/s/ Bruce E. Kiddoo
|
|
|
|
|
|
|
|
|
|
Bruce E. Kiddoo
|
|
|
|
|
Senior Vice President and Chief Financial Officer
|
|
1.
|
the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
|
2.
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
|
|
By:
|
/s/
Tunç Doluca
|
|
|
|
|
|
Tunç Doluca
President and Chief Executive Officer
|
1.
|
the Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and
|
2.
|
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
|
|
By:
|
/s/ Bruce E. Kiddoo
|
|
|
|
|
|
Bruce E. Kiddoo
Senior Vice President and Chief Financial Officer
|